Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in cases of advanced alcohol-related cirrhosis. This is shown by an international multicenter study led by MedUni Vienna, which was recently published in the…
We’re proud to share a major milestone for the A-TANGO Consortium: the latest publication is now available in the Journal of Hepatology: Highlights of this important publication: This study in global cohorts of patients with acute decompensation of cirrhosis aimed…
Geneva, 18 February 2026 – The European Association for the Study of the Liver (EASL) has called on WHO Member States to support a landmark World Health Organization (WHO) draft resolution, “Steatotic Liver Disease – A Missing Piece in the…
EASL invites you to watch this on-demand webinar bringing together leading experts from across Europe to explore why early detection of chronic liver disease must become a priority in primary care. Through real-world experiences, the panel discusses how primary care…
PRESS RELEASE 3 December 2025 On behalf of the European Health Alliance on Alcohol (EHHA), the European Association for the Study of the Liver (EASL) welcomes the European Parliament’s decision to safeguard consumers by endorsing clear and accurate “reduced-alcohol” labelling…
The DECISION consortium has just published a fundamental study in the Journal of Hepatology on immune mechanisms predicting outcomes in patients with acutely decompensated cirrhosis (ADC). By analysing whole-blood RNA-sequencing (RNA-seq) data from over 1,200+ patients, researchers identified maladaptive emergency…
In recent years, the Journal of Hepatology has witnessed a marked increase in the number of Letters to the Editor submitted for consideration. While we continue to value thoughtful academic dialogue and constructive critique of published work, we have observed…
Amsterdam, May 2, 2024 – New evidence reveals global underassessment and undertreatment of chronic hepatitis B (HBV), especially among women and Asian minorities in the West, a new study in the Journal of Hepatology, published by Elsevier, details. "In clinical practice…
The Journal of Hepatology, EASL's flagships journal, has been in circulation since 1985. With an Impact Factor of 25.7 as of 2022, it stands as the foremost hepatology-exclusive journal. Journal of Hepatology is an innovative Journal publishing articles on global…
Amsterdam, October 6, 2022 – A new analysis reveals that primary liver cancer was among the top three causes of cancer death in 46 countries in 2020 and the number of people diagnosed with or dying from primary liver cancer…